Regenics vs LTTL: Which telehealth GLP-1 option fits you best
Regenics vs LTTL compares two telehealth options that both offer compounded GLP-1 medications with clinician review. Early verdict: choose Regenics if you want nurse-practitioner-led care, a Sermorelin peptide add-on, and a lower promotional first-month price for semaglutide; choose LTTL if you prioritize an advertised up-to-$140 first-month credit and lab verification claims for compounded doses.
Quick comparison summary: Regenics vs LTTL
Both providers offer clinician-reviewed, telehealth delivery of compounded GLP-1 medications and state that compounded medications are not FDA-approved finished products. Key differences appear in pricing promotions, clinical oversight, pharmacy verification language, and optional therapies.
Top differences to weigh
1. First-month pricing and renewal terms
Regenics lists semaglutide at $139 for the first month and tirzepatide at $189 for the first month, noting promotional pricing applies to the first month and renewals increase to $199 and $279 respectively. LTTL advertises up to $140 off your first month with a code auto-applied and states pricing details may vary and should be confirmed before enrollment. Pricing beyond these promotional statements was not supplied in detail for LTTL.
Check LTTL offers and eligibility
2. Clinical oversight and who conducts reviews
Regenics describes care as nurse-practitioner-led with licensed nurse practitioners reviewing intake before anything is prescribed and treatment available only when a licensed clinician determines it is medically appropriate. LTTL describes clinician-reviewed online weight-management treatment and likewise states treatment is available only when a licensed clinician determines it is medically appropriate. Both require clinician review.
See Regenics clinician process
3. Pharmacy and lab verification language
Regenics says medications are compounded by licensed U.S. pharmacies and that its pharmacy network is LegitScript certified. LTTL states medications are compounded by U.S. licensed pharmacies, prepared in state-licensed pharmacies, and independently verified in FDA registered labs with confirmation every 3 to 6 months to stay within plus or minus 10 percent of target strength. Both include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
4. Additional therapies and product positioning
Regenics explicitly offers a Sermorelin peptide add-on and lists a 15mg Sermorelin injectable priced at $399 in its captured FAQ. LTTL positions itself as providing full-dose GLP-1 compounded medications formulated to help regulate appetite and promote fullness, and highlights consistent dose pricing claims. LTTL also emphasizes that patients should confirm eligibility, medication, total cost, renewal terms and state availability before enrollment.
Comparison table: Regenics vs LTTL
| Criterion | Regenics | LTTL |
|---|---|---|
| First-month price | Semaglutide $139 first month; tirzepatide $189 first month | Up to $140 off first month; specific first-month pricing advertised as a promotion |
| Renewal pricing | Semaglutide renews at $199/mo; tirzepatide renews at $279/mo unless otherwise stated | Renewal terms not published in captured evidence; pricing may change |
| Clinical review | Licensed nurse practitioners review intake; clinician determines appropriateness | Clinician-reviewed online treatment; clinician determines appropriateness |
| Pharmacy verification | Compounded in U.S. licensed compounding pharmacies; LegitScript certified network | Compounded in U.S. licensed and state-licensed pharmacies; verified in FDA registered labs |
| Additional therapy | Offers Sermorelin peptide therapy add-on | No additional peptide product captured in evidence |
| Regulatory note | Compounded medications are not FDA-approved finished products | Compounded medications are not FDA-approved finished products |
Practical considerations when deciding
If first-month outlay and a clear published renewal amount matter, Regenics provides explicit promotional first-month prices and specifies renewal rates in its FAQ capture. If you want an advertised auto-applied credit and emphasis on independent lab verification and consistent dose pricing language, LTTL highlights up to $140 off the first month and independent verification in FDA registered labs. Both require clinician review and both note compounded medications are not FDA-approved finished products.
Review LTTL enrollment details
Compare Regenics treatment options
Conclusion: Regenics vs LTTL
Regenics vs LTTL both deliver clinician-reviewed access to compounded GLP-1 medications with telehealth workflows and share the regulatory note that compounded medications are not FDA-approved. Regenics stands out for nurse-practitioner-led care, a Sermorelin add-on, and explicit first-month and renewal pricing. LTTL stands out for an advertised up-to-$140 first-month credit auto-applied at checkout and claims of independent verification in FDA registered labs.
Choose Regenics if you want nurse-practitioner-led telehealth care, a Sermorelin peptide add-on, and clear first-month and renewal pricing disclosures. Choose LTTL if you prioritize an advertised up-to-$140 first-month credit and independent lab verification claims and will confirm eligibility and renewal terms before enrolling.